Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2021
Daniel Pollyea, MD
Targeting Myeloid Malignancy Stem Cells Through the Pursuit of Novel Clinical Trials
Read More
2021
Akash Patnaik, MD, PhD, MMSc
Investigating the Therapeutic Potential for STING Agonists to Overcome Resistance to Immune...
Read More
2021
David Masopust, PhD
Intra-tumoral activation of antiviral CD8 T cells for tumor immunotherapy
Read More
2021
Adrian Krainer, PhD
Antisense Oligonucleotide Therapy for H3.3 K27M Diffuse Midline Gliomas
Read More
2021
Jun Wang, PhD
Reprogramming the tumor microenvironment via a PDL1 Orthogonal Immune Checkpoint Inhibitor
Read More
2021
Andrew Volk, PhD
The chromatin assembly complex drives leukemogenesis by directing RNA polymerase occupancy on...
Read More
2021
Andrew Venteicher, MD, PhD
Identifying non-genetic drivers in cancers that lack coding mutations *The research project...
Read More
2021
Amy Lee, PhD
Translational Control of the Cancer Gene Program
Read More
2021
Jeffrey Ishizuka, MD, DPhil
Defining and Overcoming Hypoxic Immune Dysfunction in Head and Neck Cancer
Read More
2021
Matthew Hangauer, PhD
Immunotherapy-Tolerant Cancer Persister Cells
Read More
2021
Christopher Halbrook, PhD
Overcoming Metabolic Heterogeneity to Target Pancreatic Cancer
Read More
2021
Berkley Gryder, PhD
3D Dependencies of Rhabdomyosarcomas Driven by a MYC-mimicking Mutation in MYOD1
Read More
2021
Adam Courtney, PhD
Modulating JAK-STAT signaling in cancer
Read More
2021
Timothy Cragin Wang, MD
Targeting myeloid cells to enhance immune checkpoint blockade in gastric cancer
Read More
2021
Nina Salama, PhD
The oral commensal bacterium Fusobacterium nucleatum as a potential driver of gastric...
Read More
2021
Shivani Srivastava, PhD
Overcoming mechanisms of resistance to AP-1 engineered CAR-T cell therapy *The Translational...
Read More